Description |
EPH receptor B4 |
claudin 3 |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Dasatinib
- N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
- N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE
- N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE
- 3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide
- N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine
- N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE
- N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE
- 3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE
- Tesevatinib
- Fostamatinib
|
|
Diseases |
|
|
GWAS |
|
|
Interacting Genes |
9 interacting genes:
APP
CLDN3
DNAJB6
EFNB2
EMILIN1
FBXO7
GRIN1
MAP3K4
SDC3
|
8 interacting genes:
APP
CLDN1
CLDN5
EPHB4
POM121
PRKACA
TJP1
WNK4
|
Entrez ID |
2050 |
1365 |
HPRD ID |
02481 |
04219 |
Ensembl ID |
ENSG00000196411
|
ENSG00000165215
|
Uniprot IDs |
P54760
Q541P7
Q96L35
|
O15551
Q75L79
|
PDB IDs |
2BBA
2E7H
2HLE
2QKQ
2VWU
2VWV
2VWW
2VWX
2VWY
2VWZ
2VX0
2VX1
2X9F
2XVD
2YN8
3ZEW
4AW5
4BB4
6FNI
6FNJ
6FNK
6FNL
6FNM
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|